Lung Cancer Clinical Trials

Find Lung Cancer Clinical Trials Near You

Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics (LUNG-IS) - PATIENT

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The long-term goal of this program of research is to increase the reach of Lung Cancer Screening (LCS) among low-resource healthcare settings and populations. The proposed project, LUNG-IS, is a mixed-methods, pre-post quasi-experimental design conducted in three Utah safety-net healthcare system clinics. LUNG-IS employs a comprehensive conceptual model with theories, models, and frameworks of implementation and behavioral science, uses rigorous mixed-methods to evaluate factors that influence implementation of LCS, and uses patient navigation to facilitate clinic-community linkages. LUNG-IS leverages existing pathways to care and Centralized Hub infrastructure that enables eligibility assessment, LCS Shared Decision Making (SDM) with clinical decision support, screening referral, and screening logistics assistance to help overcome barriers to LCS completion. The Centralized Hub model uses ubiquitous technologies (i.e., text messaging/telehealth) to enable patients to be assessed for LCS eligibility, engage in SDM if eligible, and be referred for LCS. For patients who decide to complete LCS, they will be provided patient navigation via Community Health Workers designed to address logistical barriers, hesitancy, and financial constraints around completing LCS.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 80
Healthy Volunteers: t
View:

• Current or former, male and female, smokers.

• Age 50-80.

• Primary language English or Spanish.

• Have a phone that can send/receive text messages.

Locations
United States
Utah
Huntsman Cancer Institute/ University of Utah
RECRUITING
Salt Lake City
Contact Information
Primary
Indy Li, MS
indy.li@hci.utah.edu
801-213-5697
Time Frame
Start Date: 2026-01-01
Estimated Completion Date: 2027-01
Participants
Target number of participants: 800
Treatments
Other: Stage 1: TM+
Basic text messages sent directly to the patient's cell phone.
Other: Stage 1: TM+, CA
Basic text messages sent directly to the patient's cell phone. Also includes the option for chat bot to answer frequently asked LCS questions.
Other: Stage 1: TM+, Video
Basic text messages sent directly to the patient's cell phone. Also includes the option for an educational video about LCS.
Other: Stage 1: TM+, CA, Video
Basic text messages sent directly to the patient's cell phone. Also includes the option for chat bot to answer frequently asked LCS questions and option for educational video about LCS.~Patients who complete SDM and are referred to LCS will also be assigned to one of the following conditions. Descriptions of these conditions are as follows:
Other: Stage 2: TM+, RPN
Patients who complete SDM and are referred to LCS may be assigned to this condition~Patients will receive basic text messages and reactive patient navigation to help get to the LCS appointment.
Other: Stage 2:TM+, PPN
Patients who complete SDM and are referred to LCS may be assigned to this condition~Patients will receive basic text messages and proactive patient navigation to help get to the LCS appointment.~Patients who need transportation financial assistance will receive transportation vouchers to help get them to and from their LCS appointment.
Related Therapeutic Areas
Sponsors
Collaborators: Centers for Disease Control and Prevention
Leads: University of Utah

This content was sourced from clinicaltrials.gov